Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

22. Oct 2019 | 2 min read

Gentian's CEO Dr Hilja Ibert @ BIOTALK podcast

 

Podcast: CEO Dr Hilja Ibert at BioTalk

Gentian’s CEO Dr Hilja Ibert, PhD, joined BioTalk host Rich Bendis, Founder, President and CEO BioHealth Innovation Inc. at the Capital Region Investor Conference last week. In this podcast Dr Ibert talks about Gentian’s presence in the US market, biomarkers and how Gentian focuses on innovating diagnostic efficiency.

Listen to the podcast now:

 

 

HiljaandRichRecording_web-ready

 

BioHealth Innovation and Gentian

Gentian’s subsidiary in the US, Gentian USA, Inc. collaborates with BioHealth Innovation (BHI) in order to expand Gentian’s presence in the USA. BHI is an innovation intermediary that translates relevant market research into commercial success by connecting management, funding, and markets. The collaboration allows Gentian to support current and new US customers and OEM partners more closely, and will also make Gentian's products more visible to a larger US customer base.

 

You may also read


CEO Interview at Arctic Securities

Jan 17, 2020

CEO Interview at Arctic Securities

Our CEO Dr. Hilja Ibert recently sat down with Pål Falck in Arctic Securities to have a look at Gentian's..

Diagnostic Efficiency by Gentian - Newsletter H1-2020

Jan 14, 2020

Diagnostic Efficiency by Gentian - Newsletter H1-2020

  Happy New Year 2020 We look forward to exhibiting at and visiting numerous trade shows and congresses..

CEO interview from DNB North American Life Science Conference

Jan 10, 2020

CEO interview from DNB North American Life Science Conference

Gentian’s CEO Dr Hilja Ibert was interviewed at DNB North American Life Science Conference in December 2019...